XML 14 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' (DEFICIT) EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Treasury Stock
Accumulated other comprehensive income (loss)
Accumulated deficit
Balance at Dec. 31, 2021 $ 80,674 $ 10 $ 892,828 $ (25,097) $ (6,036) $ (781,031)
Balance, shares at Dec. 31, 2021   99,537        
Sales agent equity incentives 3,068   3,068      
Sales agent equity incentives, shares   221        
Stock-based compensation 37,591   37,591      
Common stock issued for conversion of Series A preferred stock, shares   29        
Common stock issued for warrant exercises 4,160 $ 1 4,159      
Common stock issued for warrant exercises, shares   3,820        
Common stock issued for employee stock purchase plan and stock option exercises 4,020   4,020      
Common stock issued for employee stock purchase plan and stock option exercises, shares   806        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (11,220)   (11,220)      
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares   2,204        
Reclassification of liability-classified awards 2,841   2,841      
Common stock issued for asset acquisition 250   250      
Common stock issued for asset acquisition, shares   23        
Foreign currency translation adjustments (4,758)       (4,758)  
Net loss (151,293)         (151,293)
Balance at Dec. 31, 2022 (34,667) $ 11 933,537 (25,097) (10,794) (932,324)
Balance, shares at Dec. 31, 2022   106,640        
Stock-based compensation 81,244   81,244      
Common stock issued for warrant exercises 670 $ 1 669      
Common stock issued for warrant exercises, shares   5,571        
Common stock issued for employee stock purchase plan and stock option exercises 4,353   4,353      
Common stock issued for employee stock purchase plan and stock option exercises, shares   774        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (6,061)   (6,061)      
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares   6,535        
Reclassification of equity-based liability 3,561   3,561      
Common stock offerings, net of offering costs of $12,136 213,183 $ 2 213,181      
Common stock offerings, net of offering costs of $12,136, shares   19,725        
Foreign currency translation adjustments 2,471       2,471  
Net loss (186,638)         (186,638)
Balance at Dec. 31, 2023 78,116 $ 14 1,230,484 (25,097) (8,323) (1,118,962)
Balance, shares at Dec. 31, 2023   139,245        
Stock-based compensation 73,277   73,277      
Common stock issued for warrant exercises 314   314      
Common stock issued for warrant exercises, shares   63        
Common stock issued for employee stock purchase plan and stock option exercises 4,865   4,865      
Common stock issued for employee stock purchase plan and stock option exercises, shares   789        
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (7,964)   (7,964)      
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares   4,014        
Reclassification of equity-based liability 2,207   2,207      
Issuance of common stock warrant 2,244   2,244      
Common stock issued for asset acquisition 250   250      
Common stock issued for asset acquisition, shares   18        
Foreign currency translation adjustments (5,355)       (5,355)  
Net loss (162,123)         (162,123)
Balance at Dec. 31, 2024 $ (14,169) $ 14 $ 1,305,677 $ (25,097) $ (13,678) $ (1,281,085)
Balance, shares at Dec. 31, 2024   144,129